| Literature DB >> 30181118 |
Yu-Chen Guo1, Meng-Yuan Wang1, Shi-Wen Zhang1, Yun-Shu Wu1, Chen-Chen Zhou1, Ri-Xin Zheng1, Bin Shao1, Yuan Wang1, Liang Xie1, Wei-Qing Liu1, Ning-Yuan Sun1, Jun-Jun Jing1, Ling Ye1, Qian-Ming Chen1, Quan Yuan2.
Abstract
The osteogenic differentiation of mesenchymal stem cells (MSCs) is governed by multiple mechanisms. Growing evidence indicates that ubiquitin-dependent protein degradation is critical for the differentiation of MSCs and bone formation; however, the function of ubiquitin-specific proteases, the largest subfamily of deubiquitylases, remains unclear. Here, we identify USP34 as a previously unknown regulator of osteogenesis. The expression of USP34 in human MSCs increases after osteogenic induction while depletion of USP34 inhibits osteogenic differentiation. Conditional knockout of Usp34 from MSCs or pre-osteoblasts leads to low bone mass in mice. Deletion of Usp34 also blunts BMP2-induced responses and impairs bone regeneration. Mechanically, we demonstrate that USP34 stabilizes both Smad1 and RUNX2 and that depletion of Smurf1 restores the osteogenic potential of Usp34-deficient MSCs in vitro Taken together, our data indicate that USP34 is required for osteogenic differentiation and bone formation.Entities:
Keywords: bone formation; mesenchymal stem cells; osteogenic differentiation; ubiquitin‐specific protease 34
Mesh:
Substances:
Year: 2018 PMID: 30181118 PMCID: PMC6187217 DOI: 10.15252/embj.201899398
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598